Company news
AREV NanoTec Brands Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CSE Bulletin: Delist - AREV Life Sciences Global Corp. (AREV)
March 31, 2025
AREV Announces Significant Corporate Progress Amid Trading Suspension
February 6, 2024
CSE Bulletin: Suspensions (AREV, EMER)
July 20, 2023
Notice Of Default - Update
July 10, 2023
Notice Of Default - Update
July 10, 2023
Notice of Default - Update
June 12, 2023
Notice of Default - Update
May 29, 2023
Notice of Default - Update
May 15, 2023
AREV Implements AI as a Driving Force to Identify Science Backed Compounds Synergistic to its Proprietary Extracts to Increase Efficacy of Traditional Medicine
May 9, 2023
AREV Terminates Private Placement and Term Sheet with Fiberlab, Inc.
March 27, 2023
AREV Signs Term Sheet with Fiberlab, Inc.
March 15, 2023
AREV Life Sciences Provides Annual Review for 2022 and Operational Update
February 28, 2023
Team from Queensland Brain Institute Identifies New Hericerin Derivitives from Lions Mane that Boost Nerve Growth and Enhances Memory
February 15, 2023
Arev Issues Incentive Stock Options
January 16, 2023
Arev Board Change
January 9, 2023
AREV Annual General Meeting Results
January 4, 2023
AREV Issues Shares for Debt
November 9, 2022
AREV's Issues Shares for Debt
November 8, 2022
Dr. Andrew Levinson Joins AREV Life Sciences Global Corporation Scientific Advisory Board
October 28, 2022
AREV Notes U.S. Governments $2.9 Billion Assistance to Address Food Insecurity
September 22, 2022
SUSTAINN, AREV's Ready to Use Therapeutic Foods discussed in leading article in HealthHIV
August 25, 2022
AREV Adds Dr. Apte to the SAB
August 17, 2022
AREV Corporate Update
August 17, 2022
AREV Corporate Update
August 10, 2022
AREV Life Sciences announces acceleration of the clinical development of SUSTAINN, as further predictions of global famine increase demand for Ready to Use Therapeutic Foods (RUTF)
June 15, 2022
AREV Life Sciences issues retention warrants
May 27, 2022
AREV Life Sciences enters Into Collaboration Agreement with Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
March 10, 2022
AREV Life Sciences Completes Lab and Fungi Fruiting Room Build
February 23, 2022
AREV Life Sciences Advances Developments, New Appointments, and Relationships
February 17, 2022
AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19
January 18, 2022
AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO
December 23, 2021
AREV Life Sciences Settles Pending Litigation with Harvey
December 9, 2021
AREV Life Sciences / Absolem JV Receives Extraction Results
December 2, 2021
AREV Acquires Wright & Well Essentials Inc.
November 30, 2021
AREV Life Sciences Global Corp Announces Stock Option Grant
November 8, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021
September 7, 2021
AREV Announces Brian Cameron as Chief Financial Officer
September 2, 2021
CSE Bulletin: Name Change - AREV Nanotech Brands Inc. (AREV)
August 10, 2021
AREV Changes their name to AREV Life Sciences Global Corp.
August 9, 2021
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
July 29, 2021
Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN(TM), a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation
July 22, 2021
AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director
July 20, 2021
AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subisidary, AREV Life Sciences, Inc.
July 6, 2021
AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods
June 16, 2021
AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock
June 10, 2021
Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs
June 3, 2021
AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board
June 2, 2021
AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs
June 1, 2021
AREV Nanotec Brands Inc. Announces Management Cease Trade Order Revoked
June 1, 2021
AREV Nanotec Brands Inc. Provides Management Cease Trade Order Update
May 14, 2021